More on BIOL
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.37 |
|
|||
| Open | $0.37 | ||||
| 52 Wk High | $1.98 | ||||
| 52 Wk Low | $0.65 | ||||
| Day High | $0.38 | ||||
| Day Low | $0.36 | ||||
| P/E | N/A | ||||
| EPS | $-0.25 | ||||
| Volume | 144,026 | ||||
- BIOLASE GATHERS KEY OPINION LEADERS AND DENTAL CLINICIANS TO HIGHLIGHT TONGUE-TIE TREATMENT BEST PRACTICES
- BIOLASE TO REPORT FOURTH QUARTER AND FULL YEAR 2022 RESULTS ON MARCH 28, 2023
- BIOLASE PLANS TO LAUNCH SEASON 2 OF ITS POPULAR PODCAST SERIES
- Lake Street Capital Markets Assumes Biolase (BIOL) at Buy
- BIOLASE LAUNCHES E-COMMERCE SITE TO ENHANCE POSITIVE USER EXPERIENCE AND STREAMLINE THE PURCHASING PROCESS TO CREATE GREATER EFFICIENCIES FOR DENTAL PRACTITIONERS
- Biolase (BIOL) gains Australian Therapeutic Goods Administration approval for its Waterlase solid-state dental laser system
- Biolase (BIOL) Launches New Waterlase Fractional Handpiece
- BIOLASE ENTERS THE SKIN RESURFACING MARKET IN THE U.S. WITH THE LAUNCH OF A NEW WATERLASE FRACTIONAL HANDPIECE
- BIOLASE FURTHER ENHANCES MARKET AWARENESS CAMPAIGN WITH THE MUCH ANTICIPATED LAUNCH OF NEW EDUCATION PORTAL
- BIOLASE TO PRESENT AT THE THIRD ANNUAL WINTER WONDERLAND BEST IDEAS VIRTUAL INVESTOR CONFERENCE
Entities mentioned with BIOL
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Dividend | View Related Stories »
- 13D | View Related Stories »
- FDA | View Related Stories »
- S1 | View Related Stories »
- Equity Offerings | View Related Stories »
- S3 | View Related Stories »
- Show More...
